Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
With Forzinity, US FDA Accelerated Approval Still Can Precede Confirmatory Trial Enrollment
Nov 03 2025
•
By
Sue Sutter
The FDA prioritized drug access over confirmatory trial initiation in its accelerated approval of Forzinity.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Review Profiles
More from United States